Pharma funds still under the weather
Regulatory action and competition in the US market have hit revenues
The strong bull run in S&P BSE Healthcare that commenced in early 2012 came to an end in late 2015. Since then, the index has been trending down. Pharma funds, which are benchmarked against S&P BSE Healthcare and Nifty Pharma indices, have taken a knock too. There are four funds in this sector, namely Reliance Pharma, SBI Pharma, Tata India Pharma & HealthCare and UTI Pharma & H...
Please Wait while comments are loading...
This article is closed for comments.
Please Email the Editor
Comments to:
Copyright ©2018, The Hindu Business Line